UNSPSC 85818703: Transfusion of autologous cord blood stem cells into central artery, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to transfusion of autologous cord blood stem cells into central artery, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 30263X0

UNSPSC 85818703 Transfusion of autologous cord blood stem cells into central artery, percutaneous approach is a Commodity code that shows minimal alignment between its nominal scope and recent state and local procurement activity. The code's specific focus on a specialized stem cell transfusion procedure does not match the six recent opportunities posted under this classification. Those solicitations span disability medical record summarization and independent medical examinations (Phoenix), surgical benefit carve-out program management (Long Beach), occupational medical surveillance (Washington State Ferries), emergency and specialty healthcare for detained youth (Harris County), pharmacy benefit management (Collier County), and temporary health professional staffing across ancillary clinical categories (Santa Clara County Health System). None of these procurements involve cord blood stem cell therapies or the specific percutaneous arterial transfusion procedure the code nominally describes. The issuing bodies are geographically dispersed across Arizona, California, Washington, Texas, and Florida, spanning municipal retirement offices, city health programs, state transportation agencies, county juvenile justice departments, county human resources divisions, and county health systems.

Because the code shows no recent state and local activity relevant to its actual commodity scope, this code does not present actionable procurement opportunity for vendors providing autologous cord blood stem cell transfusion services to state and local government. The mismatch between the code's classification and the work being solicited suggests a tagging error across multiple posting systems rather than a live market signal. Vendors in regenerative medicine or cellular therapeutics should not rely on this code tier for prospecting; state and local governments do not appear to be sourcing these specialized medical procedures through procurement taxonomy at this granularity.